Evidence map›Paper›PMID 32640993›Full record

ArticleBMC microbiology2020

Flow-cytometry analysis reveals persister resuscitation characteristics.

Sayed Golam Mohiuddin, Pouria Kavousi, Mehmet A Orman

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Glycerol-Driven Energy and Proteostasis Underpin Antibiotic Tolerance inbioRxiv : the preprint server for biology · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. UNRAVELING CRP/cAMP-MEDIATED METABOLIC REGULATION INbioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. An ecological and stochastic perspective on persisters resuscitation.Computational and structural biotechnology journal · 2025
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Characterization ofMicroorganisms · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sayed Golam MohiuddinDepartment of Chemical and Biomolecular Engineering, University of Houston, S222 Engineering Bldg 1, 4726 Calhoun Rd, Houston, TX, 77204, USA.
Pouria KavousiDepartment of Chemical and Biomolecular Engineering, University of Houston, S222 Engineering Bldg 1, 4726 Calhoun Rd, Houston, TX, 77204, USA.
Mehmet A OrmanDepartment of Chemical and Biomolecular Engineering, University of Houston, S222 Engineering Bldg 1, 4726 Calhoun Rd, Houston, TX, 77204, USA. morman@central.uh.edu.
University of Houston · US

Funding

Characterizing a Self-Digesting-Mediated Reversible Drug Tolerance Mechanism in BacteriaR01AI143643 · NIAID · UNIVERSITY OF HOUSTON · PI ORMAN, MEHMET A. · 2020 to 2024
$1.9M
Investigating "viable but non-culturable" Cell and Persister Formation MechanismsK22AI125468 · NIAID · UNIVERSITY OF HOUSTON · PI ORMAN, MEHMET A. · 2018 to 2019
$270k
NIAID NIH HHS K22 AI125468NIAID NIH HHS R01 AI143643
6 · The paper itself

Abstract

backgroundPersisters and viable but non-culturable (VBNC) cells are two phenotypic variants known to be highly tolerant to antibiotics. Although both cell types are stained as live and often appear as nongrowing during antibiotic treatment, the only distinguishing feature is the ability of persisters to recolonize in standard culture media in the absence of antibiotics. Despite considerable progress in the characterization of persister formation mechanisms, their resuscitation mechanisms remain unclear due to technical limitations in detecting and isolating these cell types in culture environments that are highly heterogeneous.

resultsIn this study, we used a methodology integrating flow cytometry, fluorescent protein expression systems and ampicillin-mediated cell lysing technique to monitor persister resuscitation at the single-cell level. With this method, we were able to investigate the effects of various culture conditions (e.g., antibiotic treatment time, the length of the stationary phase in overnight pre-cultures, or pretreatment of cells with a metabolic inhibitor) on persister resuscitation. Although we observed long-term pre-cultures have many more VBNC cells compared to short-term pre-cultures, only a small fraction of non-lysed cells was able to resuscitate in all conditions tested. Regardless of pre-culturing and ampicillin treatment times, these persister cells started to resuscitate within 1 hour, after they were transferred to fresh liquid media, with the same doubling time that normal cells have. Our analysis further showed that ampicillin was not able to lyse the cells in the presence of arsenate, a metabolic inhibitor commonly used to increase bacterial persistence. However, the removal of arsenate during antibiotic treatment resulted in cell lysis and a reduction in persister levels despite the significant decrease in ATP levels in the cells.

conclusionsThe strategy presented in this study helps us monitor persister resuscitation at the single-cell level, and simultaneously quantify persister, VBNC and dead cell subpopulations in ampicillin-treated cultures. Our results indicate that the characterization of persister resuscitation with flow cytometry will enhance the current molecular-level understanding of persistence and its evolution.

Indexed as

Adenosine TriphosphateAmpicillinAnti-Bacterial AgentsArsenatesDrug Resistance, Multiple, BacterialEscherichia coliFlow CytometryMicrobial Sensitivity TestsMicrobial ViabilitySingle-Cell AnalysisAdenosine TriphosphateAmpicillinAnti-Bacterial AgentsArsenatesarsenic acidArsenate pretreatmentATP depletionBeta-lactamsEscherichia coliFlow cytometryFluorescent proteinsPersister resuscitationSingle-cell analysisViable but non-culturable cells

Identifiers

PMID32640993
PMCPMC7346475
OpenAlexW3040861520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.